Longaeva Partners’s Arcturus Therapeutics ARCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.36M Buy
+245,653
New +$2.57M 0.07% 211

Other funds holding ARCT

Longaeva Partners's ARCT Position: Q3 2026 in Review

Longaeva Partners opened a new position in Arcturus Therapeutics (ARCT) in Q3 2026: 245,653 shares worth $3.36M. The stake represents 0.07% of the portfolio and ranks #211 among its holdings.

155 funds tracked by Wall St. Rank hold ARCT as of Q3 2026.

  • Longaeva Partners held 245,653 shares of Arcturus Therapeutics worth $3.36M as of Q3 2026.
  • Arcturus Therapeutics was a new Longaeva Partners position in Q3 2026.
  • Arcturus Therapeutics made up 0.07% of Longaeva Partners's portfolio in Q3 2026, its #211 holding.
  • 155 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q3 2026.

Based on Longaeva Partners's 13F filing for Q3 2026, filed 16 Nov 2026.